THY1 and breast cancer: Recently, Mezheyeuski et al. (2020) analyzed five cancer-associated fibroblast (CAF) markers, stroma-based, alpha smooth muscle actin (ASMA), CD90/Thy-1, fibroblast activation protein (FAP), platelet-derived growth factor receptor-alpha and -beta (PDGFRa-b) with survival and histopathological characteristics in 344 BC patients (231 NMIBCs, 113 MIBCs).